When I was first diagnosed with diabetes in October 2002, my doctor first believed I had type 2 diabetes. It wasn’t until early 2003, after more testing that I learned … Continue reading “Until There’s A Cure”
Financial Times features Livongo.
Digital disrupters take big pharma ‘beyond the pill’
Start-ups are developing gadgets that are reducing the need for medication
by: Sarah Neville in London
After Maggie Philyaw developed Type 2 diabetes, she found solace not in the medicines of the pharmaceutical industry, but the technology of Silicon Valley. Two years ago, her then employer in North Carolina signed Ms Philyaw up to a programme run by Livongo Health, a California-based start-up, which gave her a device, smaller than an iPhone and fitted with a cellular chip, that keeps track of her blood sugar levels.
The Northeast Business Group on Health released “Digital Diabetes Solutions in Action: An Opportunity Study.” The report profiles implementation of the Livongo for Diabetes program at Mount Sinai Health System and Iron Mountain.
“Diabetes shows no signs of abating as a key concern for our employer members, despite investments in a wide range of targeted diabetes prevention and management strategies over the years, including biometric screenings, nutrition and exercise counseling, onsite clinics and incentives for diabetes medication adherence,” said Laurel Pickering, President and CEO of NEBGH. “So the question is whether investing in digital health solutions is a worthwhile addition to these strategies. Based on the Mt. Sinai pilot program as well as discussions with Iron Mountain, another employer who implemented the Livongo for Diabetes program, we think the answer is a qualified ‘yes’ — as long as employers are willing to set clear objectives, carefully select a digital partner, be prepared for challenges and decide in advance what measures they will use to gauge success.”
Livongo announced a partnership with Glytec to offer eGlycemic Management System®, or eGMS®, to Livongo members. With this alliance, Livongo and Glytec will partner to deliver an expanded diabetes management solution that includes insulin titration, making managing diabetes easier for members and their providers.